RxSight, Inc. Accumulated Other Comprehensive Income
RxSight, Inc. (RXST) had Accumulated Other Comprehensive Income of -$59.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-05
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$59.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$67.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $53.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $60.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$59.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | -$67.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $53.00K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $60.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$117.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $15.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $166.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $521.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$118.00K 10-Q · filed 2024-08-05 |
| 2024-03-31 | -$53.00K 10-Q · filed 2024-05-06 |
| 2023-12-31 | -$5.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | -$60.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$73.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | -$9.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$95.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | -$138.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$183.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$98.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$20.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | -$11.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$3.00K 10-Q · filed 2021-09-09 |
| 2020-12-31 | -$3.00K 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |